ANDA 40131, held by Hospira. Edrophonium Chloride.
As of Nov 21, 2026, ANDA 40131 (Edrophonium Chloride), held by Hospira, was first approved by FDA on Feb 24, 1998, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 24, 1998 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Edrophonium Chloride10MG/ML · injectable;injection | Edrophonium Chloride | Discontinued |
| Feb 14, 2001 | Supplement 1Manufacturing | Approved | None posted |
| Feb 24, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters